Correlation Between MediciNova and Entera Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MediciNova and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Entera Bio, you can compare the effects of market volatilities on MediciNova and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Entera Bio.

Diversification Opportunities for MediciNova and Entera Bio

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between MediciNova and Entera is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of MediciNova i.e., MediciNova and Entera Bio go up and down completely randomly.

Pair Corralation between MediciNova and Entera Bio

Given the investment horizon of 90 days MediciNova is expected to generate 1.36 times less return on investment than Entera Bio. But when comparing it to its historical volatility, MediciNova is 1.18 times less risky than Entera Bio. It trades about 0.19 of its potential returns per unit of risk. Entera Bio is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  178.00  in Entera Bio on September 15, 2024 and sell it today you would earn a total of  42.00  from holding Entera Bio or generate 23.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MediciNova  vs.  Entera Bio

 Performance 
       Timeline  
MediciNova 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.
Entera Bio 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entera Bio are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Entera Bio showed solid returns over the last few months and may actually be approaching a breakup point.

MediciNova and Entera Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MediciNova and Entera Bio

The main advantage of trading using opposite MediciNova and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.
The idea behind MediciNova and Entera Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamental Analysis
View fundamental data based on most recent published financial statements
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Technical Analysis
Check basic technical indicators and analysis based on most latest market data